Skip to main content
Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
8.70
-0.15 (-1.69%)
Apr 28, 2026, 4:14 PM GMT

Shield Therapeutics Revenue

In the year 2025, Shield Therapeutics had annual revenue of $49.70M USD with 54.45% growth. Shield Therapeutics had revenue of $28.25M in the half year ending December 31, 2025, with 202.44% growth.

Revenue
$49.70M
Revenue Growth
+54.45%
P/S Ratio
2.56
Revenue / Employee
$788.90K
Employees
63
Market Cap
94.56M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202549.70M17.52M54.45%
Dec 31, 202432.18M19.10M145.93%
Dec 31, 202313.09M7.59M137.95%
Dec 31, 20225.50M3.44M167.35%
Dec 31, 20212.06M-12.12M-85.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Venture Life Group 35.17M
ECO Animal Health Group 85.81M
Provexis 871.27K
Allergy Therapeutics 57.29M
HUTCHMED (China) 407.54M
Hikma Pharmaceuticals 2.49B
Chill Brands Group 370.50K
Haleon 11.03B
Revenue Rankings

Shield Therapeutics News

More News